AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2022
Apr 28, 2022
34491_dirs_2022-04-28_130e0f11-8b3c-43d9-879e-6dd41060fda4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-04-26
Reporting Person: List Alan (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-26 | Common Stock | M | 26035 | — | Acquired | 26035 | Direct |
| 2022-04-27 | Common Stock | S | 7775 | $2.10 | Disposed | 18260 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-26 | Restricted Stock Units | $ | M | 26035 | Disposed | Common Stock (26035) | Direct |
Footnotes
F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2022.
F2: Each RSU represents a contingent right to receive one share of the Company's Common Stock.
F3: The sale was effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.